APRE · Categories · Form 4

APRE - SEC Form 4 insider transactions

Aprea Therapeutics Inc. (APRE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for APRE

• 70d
  SEC Form 4 filed by Hamill John P.

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 70d
  SEC Form 4 filed by Peters Richard

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 86d
  President/CEO Gilad Oren was granted 20,175 shares, increasing direct ownership by 5% to 393,895 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 86d
  SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. was granted 10,095 shares, increasing direct ownership by 30% to 43,528 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 182d
  SEC Form 4 filed by President/CEO Gilad Oren

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Seizinger Bernd R. was granted 1,045 shares, increasing direct ownership by 2% to 45,775 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Peters Richard was granted 1,045 shares, increasing direct ownership by 50% to 3,119 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Pamukcu Rifat was granted 1,045 shares, increasing direct ownership by 24% to 5,446 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Henneman John B Iii was granted 1,045 shares, increasing direct ownership by 11% to 10,229 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Gruia Gabriela was granted 1,045 shares (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Grissinger Michael was granted 1,045 shares, increasing direct ownership by 57% to 2,889 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Duey Marc was granted 1,045 shares, increasing direct ownership by 0.45% to 234,696 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 366d
  Director Bizzari Jean-Pierre was granted 1,045 shares (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 436d
  SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. was granted 3,365 shares, increasing direct ownership by 17% to 22,733 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 436d
  President/CEO Gilad Oren was granted 6,725 shares, increasing direct ownership by 2% to 340,120 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 593d
  Director Duey Marc sold $29,583 worth of shares (6,462 units at $4.58), decreasing direct ownership by 3% to 233,651 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Seizinger Bernd R. was granted 1,045 shares, increasing direct ownership by 3% to 34,730 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Pamukcu Rifat was granted 1,045 shares, increasing direct ownership by 31% to 4,401 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Peters Richard was granted 1,045 shares, increasing direct ownership by 102% to 2,074 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Henneman John B Iii was granted 1,045 shares, increasing direct ownership by 13% to 9,184 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Grissinger Michael was granted 1,045 shares, increasing direct ownership by 131% to 1,844 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 719d
  Director Duey Marc was granted 1,045 shares, increasing direct ownership by 0.50% to 209,923 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 769d
  Mirza Nadeem Q. was granted 6,730 shares (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 804d
  Hamill John P. was granted 3,365 shares, increasing direct ownership by 22% to 18,868 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 804d
  Gilad Oren was granted 6,725 shares, increasing direct ownership by 2% to 331,495 units (SEC Form 4)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Pamukcu Rifat was granted 500 shares and converted options into 321,150 shares, decreasing direct ownership by 57% to 3,356 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Grissinger Michael was granted 500 shares, increasing direct ownership by 167% to 799 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Henneman John B Iii was granted 500 shares, increasing direct ownership by 64% to 1,279 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Peters Richard was granted 500 shares, increasing direct ownership by 95% to 1,029 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Duey Marc converted options into 4,021,300 shares and was granted 500 shares, increasing direct ownership by 32% to 208,878 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4: Seizinger Bernd R. was granted 500 shares, increasing direct ownership by 2% to 26,825 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 4 filed by Bizzari Jean-Pierre

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1098d
  SEC Form 4 filed by Seizinger Bernd R.

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1129d
  SEC Form 4 filed by Gruia Gabriela

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1185d
  SEC Form 4: Gilad Oren converted options into 6,045,100 shares and was granted 4,000 shares, decreasing direct ownership by 2% to 322,770 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1199d
  SEC Form 4: Hamill John P. was granted 1,000 shares, increasing direct ownership by 7% to 14,493 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1227d
  SEC Form 4: Hamill John P. was granted 269,879 shares

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Seizinger Bernd R. was granted 5,995 shares, increasing direct ownership by 2% to 324,575 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Schade Christian S was granted 32,400 shares, increasing direct ownership by 14% to 259,246 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Peters Richard was granted 5,995 shares, increasing direct ownership by 130% to 10,605 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Pamukcu Rifat was granted 5,995 shares, increasing direct ownership by 321% to 7,862 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Korbel Gregory Alan was granted 24,300 shares, increasing direct ownership by 113% to 45,762 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Henneman John B Iii was granted 5,995 shares, increasing direct ownership by 62% to 15,605 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Grissinger Michael was granted 5,995 shares

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Gilad Oren was granted 101,300 shares, increasing direct ownership by 44% to 330,314 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Duey Marc was granted 5,995 shares, increasing direct ownership by 4% to 157,899 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1409d
  SEC Form 4: Coiante Scott M was granted 60,800 shares, increasing direct ownership by 72% to 145,065 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1464d
  SEC Form 4: Schade Christian S covered exercise/tax liability with 65,770 shares, decreasing direct ownership by 22% to 226,846 units to cover withholding tax

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1464d
  SEC Form 4: Coiante Scott M covered exercise/tax liability with 35,284 shares, decreasing direct ownership by 30% to 84,265 units (for withholding tax)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1464d
  SEC Form 4: Korbel Gregory Alan covered exercise/tax liability with 8,390 shares, decreasing direct ownership by 28% to 21,462 units to satisfy withholding tax

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1464d
  SEC Form 4: Attar Eyal C. covered exercise/tax liability with 32,667 shares, decreasing direct ownership by 36% to 57,233 units (for tax liability)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1483d
  SEC Form 4: Seizinger Bernd R. bought $35,500 worth of shares (50,000 units at $0.71), increasing direct ownership by 19% to 318,580 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1483d
  SEC Form 4: Schade Christian S bought $24,124 worth of shares (37,500 units at $0.64), increasing direct ownership by 15% to 292,616 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1549d
  SEC Form 4: Schade Christian S was granted 100,100 shares, increasing direct ownership by 65% to 255,116 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1549d
  SEC Form 4: Korbel Gregory Alan was granted 16,000 shares and covered exercise/tax liability with 1,989 shares, increasing direct ownership by 88% to 29,852 units to satisfy tax liability

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1549d
  SEC Form 4: Coiante Scott M was granted 42,900 shares, increasing direct ownership by 56% to 119,549 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1549d
  SEC Form 4: Attar Eyal C. was granted 42,900 shares, increasing direct ownership by 91% to 89,900 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1549d
  SEC Form 4: Abrahmsen Lars B. was granted 24,700 shares, increasing direct ownership by 130% to 43,700 units

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1562d
  SEC Form 4: Korbel Gregory Alan covered exercise/tax liability with 1,326 shares, decreasing direct ownership by 8% to 15,841 units to satisfy tax liability

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1562d
  SEC Form 4: Coiante Scott M covered exercise/tax liability with 14,817 shares, decreasing direct ownership by 16% to 76,649 units (for tax liability)

  4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

Other APRE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends